277 related articles for article (PubMed ID: 33033144)
1. Tumor DNA as a Cancer Biomarker through the Lens of Colorectal Neoplasia.
Cohen JD; Diergaarde B; Papadopoulos N; Kinzler KW; Schoen RE
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2441-2453. PubMed ID: 33033144
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for Early Detection of Colorectal Cancer: The Early Detection Research Network, a Framework for Clinical Translation.
Bresalier RS; Grady WM; Markowitz SD; Nielsen HJ; Batra SK; Lampe PD
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2431-2440. PubMed ID: 32299850
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Diagnostics for Early Detection of Lung Cancer: Challenges and Potential with a Focus on Changes in DNA Methylation.
Farooq M; Herman JG
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2416-2422. PubMed ID: 33148791
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of circulating tumor DNA for colorectal cancer.
Osumi H; Shinozaki E; Yamaguchi K; Zembutsu H
Cancer Sci; 2019 Apr; 110(4):1148-1155. PubMed ID: 30742729
[TBL] [Abstract][Full Text] [Related]
5. Pitfalls in Cancer Biomarker Discovery and Validation with Emphasis on Circulating Tumor DNA.
Ren AH; Fiala CA; Diamandis EP; Kulasingam V
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2568-2574. PubMed ID: 32277003
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for Lung Cancer Screening and Detection.
Ostrin EJ; Sidransky D; Spira A; Hanash SM
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2411-2415. PubMed ID: 33093160
[TBL] [Abstract][Full Text] [Related]
7. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
8. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.
Corbo C; Cevenini A; Salvatore F
Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089
[TBL] [Abstract][Full Text] [Related]
9. The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers.
Srivastava S; Wagner PD
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2401-2410. PubMed ID: 32357955
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.
Toiyama Y; Okugawa Y; Fleshman J; Richard Boland C; Goel A
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):274-282. PubMed ID: 29852194
[TBL] [Abstract][Full Text] [Related]
11. Adding Rigor to Biomarker Evaluations-EDRN Experience.
Feng Z; Pepe MS
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2575-2582. PubMed ID: 33172885
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived exosomes: Potential biomarkers and therapeutic target in the treatment of colorectal cancer.
Mousavi S; Moallem R; Hassanian SM; Sadeghzade M; Mardani R; Ferns GA; Khazaei M; Avan A
J Cell Physiol; 2019 Aug; 234(8):12422-12432. PubMed ID: 30637729
[TBL] [Abstract][Full Text] [Related]
13. Early detection: the impact of genomics.
van Lanschot MCJ; Bosch LJW; de Wit M; Carvalho B; Meijer GA
Virchows Arch; 2017 Aug; 471(2):165-173. PubMed ID: 28573511
[TBL] [Abstract][Full Text] [Related]
14. Sensitive tumour detection and classification using plasma cell-free DNA methylomes.
Shen SY; Singhania R; Fehringer G; Chakravarthy A; Roehrl MHA; Chadwick D; Zuzarte PC; Borgida A; Wang TT; Li T; Kis O; Zhao Z; Spreafico A; Medina TDS; Wang Y; Roulois D; Ettayebi I; Chen Z; Chow S; Murphy T; Arruda A; O'Kane GM; Liu J; Mansour M; McPherson JD; O'Brien C; Leighl N; Bedard PL; Fleshner N; Liu G; Minden MD; Gallinger S; Goldenberg A; Pugh TJ; Hoffman MM; Bratman SV; Hung RJ; De Carvalho DD
Nature; 2018 Nov; 563(7732):579-583. PubMed ID: 30429608
[TBL] [Abstract][Full Text] [Related]
15. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
16. Mesothelioma Biomarkers: A Review Highlighting Contributions from the Early Detection Research Network.
Pass HI; Alimi M; Carbone M; Yang H; Goparaju CM
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2524-2540. PubMed ID: 32699075
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Ma H; Chen G; Guo M
Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of Fecal Cancer-Specific DNA to Detect Colorectal Neoplasia].
Nagasaka T; Yamaguchi Y
Gan To Kagaku Ryoho; 2018 Jun; 45(6):906-910. PubMed ID: 30026411
[TBL] [Abstract][Full Text] [Related]
19. Stool DNA methylation assays in colorectal cancer screening.
Kadiyska T; Nossikoff A
World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
[TBL] [Abstract][Full Text] [Related]
20. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
